|
Re: RVX.WT RESVERLOGIX CORP WTS 2021
|
7
|
Resverlogix Corp.
|
Jun 25, 2020 10:15AM
|
|
Re: RVX-297 -- Twice as selective for BD2 as is apabetalone
|
6
|
Resverlogix Corp.
|
May 30, 2022 02:45PM
|
|
Re: RVX- Exempt Distribution
|
7
|
Resverlogix Corp.
|
Apr 01, 2022 10:01AM
|
|
Re: RVX- Exempt Distribution
|
7
|
Resverlogix Corp.
|
Apr 01, 2022 10:29AM
|
|
Re: RVX rises above 200-day moving average
|
4
|
Resverlogix Corp.
|
Sep 21, 2020 02:27PM
|
|
Re: RVX Level II - Narmac
|
1
|
Resverlogix Corp.
|
Dec 11, 2020 12:26PM
|
|
Re: RVX LEVEL II
|
3
|
Resverlogix Corp.
|
Aug 14, 2020 01:44PM
|
|
Re: RVX LEVEL II
|
2
|
Resverlogix Corp.
|
Aug 14, 2020 01:51PM
|
|
Re: RVX is warming up!
|
9
|
Resverlogix Corp.
|
Jan 25, 2022 01:59PM
|
|
Re: RVX is warming up!
|
4
|
Resverlogix Corp.
|
Jan 25, 2022 02:39PM
|
|
Re: RVX Current Status
|
9
|
Resverlogix Corp.
|
Feb 27, 2020 12:45PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
9
|
Resverlogix Corp.
|
May 10, 2022 01:18PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 09, 2022 12:56PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 09, 2022 01:08PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
8
|
Resverlogix Corp.
|
May 09, 2022 02:12PM
|
|
Re: Rumour- Glencore will increase offer by 5 billion! Wow!!
|
8
|
Copper Fox Metals Inc.
|
Apr 17, 2023 02:00PM
|
|
Re: ROFO Question
|
8
|
Copper Fox Metals Inc.
|
Nov 11, 2021 09:05AM
|
|
Re: Ridiculous programmed trading -- 95% of it Anon to Anon
|
1
|
Copper Fox Metals Inc.
|
May 16, 2024 10:07AM
|
|
Re: Resverlogix vs Moderna
|
5
|
Resverlogix Corp.
|
Jul 09, 2020 04:26PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
11
|
Resverlogix Corp.
|
Jun 22, 2020 12:14PM
|
